Metamizole sodium monohydrateProduct ingredient for Metamizole

Name
Metamizole sodium monohydrate
Drug Entry
Metamizole

Metamizole, formerly marketed as Dimethone tablets and injection, Protemp oral liquid, and other drug products, was associated with potentially fatal agranulocytosis. Approvals of the NDA's for dipyrone drug products were withdrawn on June 27, 1977 (see the Federal Register of June 17, 1977 (42 FR 30893)). Withdrawn from the Canadian market in 1963.

Accession Number
DBSALT002438
Structure
Thumb
Synonyms
Dipyrone / Dipyrone monohydrate / Metamizol monohydrate / Metamizole sodium hydrate / Methampyrone / Sulpyrine hydrate
UNII
6429L0L52Y
CAS Number
5907-38-0
Weight
Average: 351.35
Monoisotopic: 351.08648615
Chemical Formula
C13H18N3NaO5S
InChI Key
UNZIDPIPYUMVPA-UHFFFAOYSA-M
InChI
InChI=1S/C13H17N3O4S.Na.H2O/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11;;/h4-8H,9H2,1-3H3,(H,18,19,20);;1H2/q;+1;/p-1
IUPAC Name
SMILES
O.[Na+].CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1
KEGG Drug
D01762
KEGG Compound
C13229
ChemSpider
570961
ChEBI
32169
ChEMBL
CHEMBL3989803
Predicted Properties
PropertyValueSource